U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS™ in Combination Therapy for Multiple Myeloma at First Relapse Bristol Myers Squibb has announced that the U.S. Food and Drug…
Gossamer Bio Reports Second-Quarter 2026 Results and Advances Seralutinib Toward Planned FDA Submission Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing and potentially commercializing therapies for pulmonary vascular…
AIVITA Biomedical Named 2026 Prix Galien USA “Best Startup” Nominee for Personalized Immunotherapy Innovation AIVITA Biomedical, Inc., a biotechnology company developing personalized vaccines and immunotherapies for infectious diseases and cancer,…
Clinilabs Expands Leadership Team With Laura Shannon as CEO as Founder Gary Zammit Moves to Executive Chairperson Clinilabs, a specialty contract research organization (CRO) focused on the development of central…
biomodal Launches duet mosaic Workflows to Unlock More Biological Signals from Every Liquid Biopsy Sample biomodal, an omics-focused life sciences technology and analytics company, has announced the launch of its…
Amprion and MLM Medical Labs Expand Access to α-Synuclein Testing for Neurodegenerative Disease Trials Across Europe Amprion, a global leader in advancing the diagnosis and characterization of neurodegenerative disorders through…
Spruce Biosciences Secures $5.5 Million Strategic Investment to Expand Access to Investigational TA-ERT for Children With Sanfilippo Syndrome Type B Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused…
InduPro Raises $77 Million Series B and Advances Lead Oncology Program IDP-001 Into Phase 1 Clinical Development InduPro, Inc., a biotechnology company developing a new class of therapeutics based on…
Natera Collaborates With Kupando Therapeutics to Monitor Molecular Response in Phase 1 Trial of Novel Immunotherapy KUP-101 Natera, Inc., a global leader in cell-free DNA analysis and precision medicine, has…
CN Bio Secures £180,000 Innovate UK Grant to Advance Human-Relevant Organ-on-a-Chip Technology for Drug Development CN Bio, a leading developer of Organ-on-a-Chip (OOC) systems and advanced solutions designed to accelerate…
LeAnn Rimes to Join Next Health Longevity Summit in Nashville, Bringing Personal Perspective to the Future of Health Optimization With just one month remaining until the inaugural Next Health Longevity…
Integrated DNA Technologies Study Establishes New Benchmark for CRISPR Off-Target Detection and Analysis Integrated DNA Technologies (IDT), a Danaher company and a global provider of genomics solutions, has announced the…